Publicaciones en colaboración con investigadores/as de Paul Sabatier University (58)

2023

  1. Acylation of glycerolipids in mycobacteria

    Nature Communications, Vol. 14, Núm. 1

  2. Diminishing benefits of urban living for children and adolescents’ growth and development

    Nature, Vol. 615, Núm. 7954, pp. 874-883

  3. Improving outcomes of childhood and young adult non-Hodgkin lymphoma: 25 years of research and collaboration within the framework of the European Intergroup for Childhood Non-Hodgkin Lymphoma

    The Lancet Haematology, Vol. 10, Núm. 3, pp. e213-e224

2022

  1. Activation of cryptic donor splice sites by non-coding and coding PAX6 variants contributes to congenital aniridia

    Journal of Medical Genetics, Vol. 59, Núm. 5, pp. 428-437

  2. FOSL2 truncating variants in the last exon cause a neurodevelopmental disorder with scalp and enamel defects

    Genetics in Medicine, Vol. 24, Núm. 12, pp. 2475-2486

2021

  1. Finding genetically-supported drug targets for Parkinson’s disease using Mendelian randomization of the druggable genome

    Nature Communications, Vol. 12, Núm. 1

  2. Fluctuations in akt and pten activity are linked by the e3 ubiquitin ligase ccbl

    Cells, Vol. 10, Núm. 11

  3. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  4. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage

    Nature Communications, Vol. 12, Núm. 1

  5. Molecular ruler mechanism and interfacial catalysis of the integral membrane acyltransferase PatA

    Science Advances, Vol. 7, Núm. 42

2020

  1. Regulatory sites for splicing in human basal ganglia are enriched for disease-relevant information

    Nature Communications, Vol. 11, Núm. 1

2019

  1. Accurate, robust and harmonized implementation of morpho-functional imaging in treatment planning for personalized radiotherapy

    PLoS ONE, Vol. 14, Núm. 1

  2. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta-analysis of genome-wide association studies

    The Lancet Neurology, Vol. 18, Núm. 12, pp. 1091-1102

  3. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability

    npj Parkinson's Disease, Vol. 5, Núm. 1

  4. Oral phenelzine treatment mitigates metabolic disturbances in mice fed a high-fat diet

    Journal of Pharmacology and Experimental Therapeutics, Vol. 371, Núm. 2, pp. 555-566

  5. Regulation of glucose metabolism by bioactive phytochemicals for the management of type 2 diabetes mellitus

    Critical Reviews in Food Science and Nutrition, Vol. 59, Núm. 6, pp. 830-847

  6. SNCA and mTOR Pathway Single Nucleotide Polymorphisms Interact to Modulate the Age at Onset of Parkinson's Disease

    Movement Disorders, Vol. 34, Núm. 9, pp. 1333-1344

2018

  1. Metabolic effects of oral phenelzine treatment on high-sucrose-drinking mice

    International Journal of Molecular Sciences, Vol. 19, Núm. 10

  2. Safety Assessment of Graphene-Based Materials: Focus on Human Health and the Environment

    ACS Nano, Vol. 12, Núm. 11, pp. 10582-10620

  3. The Molecular Mechanism of Substrate Recognition and Catalysis of the Membrane Acyltransferase PatA from Mycobacteria

    ACS Chemical Biology, Vol. 13, Núm. 1, pp. 131-140